These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6184243)

  • 1. Reversibility of the transformed and neoplastic phenotype. III. Long-term treatment with electrophoretically pure mouse interferon leads to the progressive reversion of the phenotype of X-ray transformed C3H/10T1/2 cells.
    Brouty-Boyé D; Puvion-Dutilleul F; Gresser I
    Experientia; 1982 Nov; 38(11):1292-6. PubMed ID: 6184243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray-transformed C3H/10T1/2 cells under prolonged treatment with interferon.
    Brouty-Boyé D; Gresser I
    Int J Cancer; 1981 Aug; 28(2):165-73. PubMed ID: 6172389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibility of the transformed and neoplastic phenotype. IV. Effects of long-term interferon treatment of C3H/10T1/2 cells transformed by methylcholanthrene and SV40 virus.
    Brouty-Boyé D; Wybier-Franqui J; Calvo C; Feunteun J; Gresser I
    Int J Cancer; 1984 Jul; 34(1):107-12. PubMed ID: 6204950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased sensitivity to interferon associated with in vitro transformation of X-ray-transformed C3H/10T1/2 cells.
    Brouty-Boyé D; Gresser I; Baldwin C
    Int J Cancer; 1979 Aug; 24(2):261-5. PubMed ID: 489167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of the transformed phenotype to the parental phenotype by subcultivation of X-ray-transformed C3H/10T1/2 cells at low cell density.
    Brouty-Boyé D; Gresser I; Baldwin C
    Int J Cancer; 1979 Aug; 24(2):253-60. PubMed ID: 489166
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability of the phenotypic reversion of x-ray transformed C3H/10T1/2 cells depends on cellular proliferation after subcultivation at low cell density.
    Brouty-Boyé D; Gresser I; Bandu MT
    Carcinogenesis; 1982; 3(9):1057-61. PubMed ID: 7139862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of tolerance to the antiproliferative activity of interferon by X-ray transformed C3H/10T1/2 cells under prolonged treatment with interferon.
    Brouty-Boyé D
    Int J Cancer; 1982 Aug; 30(2):193-5. PubMed ID: 6182112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of phenotypic reversion of transformed cells induced by interferon with morphological and biochemical changes in the cytoskeleton.
    Brouty-Boyé D; Cheng YS; Chen LB
    Cancer Res; 1981 Oct; 41(10):4174-84. PubMed ID: 6169435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic rearrangements in mouse C3H/10T1/2 cells transformed by X-rays, UV-C, and 3-methylcholanthrene, detected by a DNA fingerprint assay.
    Paquette B; Little JB
    Cancer Res; 1992 Oct; 52(20):5788-93. PubMed ID: 1327516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of X-ray-induced transformation in C3H/10T1/2 cells by interferon.
    Brouty-Boyé D; Little JB
    Cancer Res; 1977 Aug; 37(8 Pt 1):2714-6. PubMed ID: 872097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by X-rays.
    Paquette B; Little JB
    Cancer Res; 1994 Jun; 54(12):3173-8. PubMed ID: 8205536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous interferon in the high sensitivity of C3H/10T1/2 cells to the antiviral activity of interferon.
    Wybier-Franqui J; Brouty-Boyé D
    J Interferon Res; 1992 May; Spec No():17-22. PubMed ID: 1379282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.
    Smith GJ; Bell WN; Grisham JW
    Cancer Res; 1993 Feb; 53(3):500-8. PubMed ID: 8425183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of genomic instability by 17beta-estradiol in minisatellite sequences of X-ray-transformed mouse 10T1/2 cells.
    Paquette B
    Carcinogenesis; 1996 Jun; 17(6):1221-5. PubMed ID: 8681435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction by growth factors from platelets of the focus-forming transformed phenotype in carcinogen-treated C3H/10T1/2 fibroblasts.
    Mordan LJ
    Carcinogenesis; 1988 Jul; 9(7):1129-34. PubMed ID: 3383332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell growth inhibitory and antiviral effects of interferon in cloned transformed mouse cells.
    Borecký L; Hajnická V; Fuchsberger N; Kontsek P; Lackovic V; Russ G; Capková J
    Ann N Y Acad Sci; 1980; 350():188-207. PubMed ID: 6165274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of X-ray induced transformation by vitamin E in mouse C3H/10T1/2 cells.
    Radner BS; Kennedy AR
    Cancer Lett; 1986 Jul; 32(1):25-32. PubMed ID: 3742485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene.
    Samid D; Chang EH; Friedman RM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):21-8. PubMed ID: 6200112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformed and neoplastic phenotype: reversibility during culture by cell density and cell shape.
    Brouty-Boyé D; Tucker RW; Folkman J
    Int J Cancer; 1980 Oct; 26(4):501-7. PubMed ID: 7251225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
    Benedict WF; Wheatley WL; Jones PA
    Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.